Chinese Journal of Stroke ›› 2023, Vol. 18 ›› Issue (12): 1337-1342.DOI: 10.3969/j.issn.1673-5765.2023.12.001
Previous Articles Next Articles
XIONG Yunyun, WANG Yongjun
Received:
2023-11-10
Online:
2023-12-20
Published:
2023-12-20
熊云云, 王拥军
通讯作者:
王拥军 yongjunwang@ncrcnd.org.cn
XIONG Yunyun, WANG Yongjun. Chinese Studies Changed the National Clinical Guideline for Stroke for the United Kingdom and Ireland[J]. Chinese Journal of Stroke, 2023, 18(12): 1337-1342.
熊云云, 王拥军. 中国研究改变英国卒中指南[J]. 中国卒中杂志, 2023, 18(12): 1337-1342.
[1] MENON B K,BUCK B H,SINGH N,et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada(AcT):a pragmatic,multicentre,open-label,registry-linked,randomised,controlled,non-inferiority trial[J]. Lancet,2022,400(10347):161-169. [2] WANG Y J,LI S Y,PAN Y S,et al. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events(TRACE-2):a phase 3,multicentre,open-label,randomised controlled,non-inferiority trial[J]. Lancet,2023,401(10377):645-654. [3] BERKHEMER O A,FRANSEN P S,BEUMER D,et al. A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med,2015,372(1):11-20. [4] GOYAL M,DEMCHUK A M,MENON B K,et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med,2015,372(11):1019-1030. [5] SAVER J L,GOYAL M,BONAFE A,et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med,2015,372(24):2285-2295. [6] JOVIN T G,CHAMORRO A,COBO E,et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med,2015,372(24):2296-2306. [7] CAMPBELL B C,MITCHELL P J,KLEINIG T J,et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med,2015,372(11):1009-1018. [8] YANG P F,ZHANG Y W,ZHANG L,et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke[J]. N Engl J Med,2020,382(21):1981-1993. [9] ZI W J,QIU Z M,LI F L,et al. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke:the DEVT randomized clinical trial[J]. JAMA,2021,325(3):234-243. [10] SUZUKI K,MATSUMARU Y,TAKEUCHI M,et al. Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke:the SKIP randomized clinical trial[J]. JAMA,2021,325(3):244-253. [11] LECOUFFE N E,KAPPELHOF M,TREURNIET K M,et al. A randomized trial of intravenous alteplase before endovascular treatment for stroke[J]. N Engl J Med,2021,385(20):1833-1844. [12] FISCHER U,KAESMACHER J,STRBIAN D,et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke:an open-label,blinded-outcome,randomised non-inferiority trial[J]. Lancet,2022,400(10346):104-115. [13] MITCHELL P J,YAN B,CHURILOV L,et al. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4.5 h of stroke onset:an open-label,blinded-endpoint,randomised non-inferiority trial[J]. Lancet,2022,400(10346):116-125. [14] WANG Y J,WANG Y L,ZHAO X Q,et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack[J]. N Engl J Med,2013,369(1):11-19. [15] JOHNSTON S C,EASTON J D,FARRANT M,et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA[J]. N Engl J Med,2018,379(3):215-225. [16] MA H,CAMPBELL B,PARSONS M W,et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke[J]. N Engl J Med,2019,380(19):1795-1803. [17] THOMALLA G,SIMONSEN C Z,BOUTITIE F,et al. MRI-guided thrombolysis for stroke with unknown time of onset[J]. N Engl J Med,2018,379(7):611-622. [18] ALBERS G W,MARKS M P,KEMP S,et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J]. N Engl J Med,2018,378(8):708-718. [19] NOGUEIRA R G,JADHAV A P,HAUSSEN D C,et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J]. N Engl J Med,2018,378(1):11-21. [20] WANG Y J,MENG X,WANG A X,et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA[J]. N Engl J Med,2021,385(27):2520-2530. [21] JOHNSTON S C,AMARENCO P,DENISON H,et al. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA[J]. N Engl J Med,2020,383(3):207-217. [22] LIU X F,DAI Q L,YE R D,et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion(BEST):an open-label,randomised controlled trial[J]. Lancet Neurol,2020,19(2):115-122. [23] LANGEZAAL L,VAN DER HOEVEN E,MONT'ALVERNE F,et al. Endovascular therapy for stroke due to basilar-artery occlusion[J]. N Engl J Med,2021,384(20):1910-1920. [24] TAO C R,NOGUEIRA R G,ZHU Y Y,et al. Trial of endovascular treatment of acute basilar-artery occlusion[J]. N Engl J Med,2022,387(15):1361-1372. [25] JOVIN T G,LI C H,WU L F,et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion[J]. N Engl J Med,2022,387(15):1373-1384. [26] SAVER J L,CARROLL J D,THALER D E,et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke[J]. N Engl J Med,2017,377(11):1022-1032. [27] MAS J L,DERUMEAUX G,GUILLON B,et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke[J]. N Engl J Med,2017,377(11):1011-1021. [28] SONDERGAARD L,KASNER S E,RHODES J F,et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke[J]. N Engl J Med,2017,377(11):1033-1042. [29] YOSHIMURA S,SAKAI N,YAMAGAMI H,et al. Endovascular therapy for acute stroke with a large ischemic region[J]. N Engl J Med,2022,386(14):1303-1313. [30] SARRAJ A,HASSAN A E,ABRAHAM M G,et al. Trial of endovascular thrombectomy for large ischemic strokes[J]. N Engl J Med,2023,388(14):1259-1271. [31] HUO X C,Ma G T,Tong X,et al. Trial of endovascular therapy for acute ischemic stroke with large infarct[J]. N Engl J Med,2023,388(14):1272-1283. [32] BUCK B H,HILL M D,QUINN F R,et al. Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with ischemic stroke:the PER DIEM randomized clinical trial[J]. JAMA,2021,325(21):2160-2168. [33] CONNOLLY S J,KARTHIKEYAN G,NTSEKHE M,et al. Rivaroxaban in rheumatic heart disease-associated atrial fibrillation[J]. N Engl J Med,2022,387(11):978-988. [34] RESTART Collaboration. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage(RESTART):a randomised,open-label trial[J]. Lancet,2019,393(10191):2613-2623. |
[1] | XU Yuming. Stroke Center Construction and Quality Control: A Long Way to Go [J]. Chinese Journal of Stroke, 2023, 18(9): 973-977. |
[2] | GAO Yuan, LIU Kai, LI Yapeng, YANG Zongyu, LI Yusheng, SONG Bo, XU Yuming. Research Progress of the Construction and Quality Control of Stroke Center [J]. Chinese Journal of Stroke, 2023, 18(9): 979-985. |
[3] | LI Yapeng, GAO Yuan, LIU Kai, YANG Zongyu, WANG Jingjing, ZHOU Lue, DONG Xiaokang, LI Yusheng, SONG Bo, XU Yuming. Exploration and Practice of the Construction of Stroke Center in Henan Province [J]. Chinese Journal of Stroke, 2023, 18(9): 986-992. |
[4] | WU Di, JING Jing, PAN Yuesong, CHEN Xuzhu, ZHAO Xingquan. Relationship between Characteristics of Ischemic Infarction Distribution and Involved Vascular Segments in Patients with Ischemic Stroke Caused by Spontaneous Carotid Artery Dissection [J]. Chinese Journal of Stroke, 2023, 18(9): 993-1000. |
[5] | JIAO Junping, BAO Junqiang, SHI Huimin, GAO Chao, TIAN Shujuan. LACC1 Aggravated Ischemia Reperfusion by Phosphorylate AMP-activated Protein Kinase/Nucleotide-binding Oligomerization Domain-like Receptor Protein 3 in Cerebral Infarction [J]. Chinese Journal of Stroke, 2023, 18(9): 1006-1013. |
[6] | ZHANG Qian, JI Ruijun, ZHAO Meng, WANG Wenjuan, LU Jingjing, LI Na, LIU Yanfang, BIAN Liheng, YU Songlin, LI Hao, ZHANG Qian, WU Jianwei, WANG Dandan, WANG Jing, LI Zhaoxia, JIANG Ruixuan, KANG Kaijiang, XUE Yimeng, YA Xiaolong, HE Qiheng, MO Shaohua, ZHAO Xingquan, ZHAO Jizong, the Writing Committee of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases ( Contributed equally). Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Excerpt) ——Chapter Five Clinical Management of Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2023, 18(9): 1014-1023. |
[7] | CHENG Xin, ZHONG Weiyi, DONG Yi, LI Qi, NI Wei, GU Hongqiu, GU Yuxiang, DONG Qiang, the Writing Committee of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases. Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Excerpt)——Chapter Six Clinical Management of Subarachnoid Hemorrhage [J]. Chinese Journal of Stroke, 2023, 18(9): 1024-1029. |
[8] | FAN Yuhua, DANG Chao, YU Jian, CHEN Hongbing, DUAN Jiangang, MO Dapeng, ZHU Wenhao, OUYANG Fubing, WANG Bo, ZENG Jinsheng, the Writing Committee of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases. Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Excerpt)——Chapter Seven Clinical Management of Cerebral Venous Thrombosis [J]. Chinese Journal of Stroke, 2023, 18(9): 1030-1035. |
[9] | ZHANG Tong, ZHAO Jun, LI Xueping, BAI Yulong, WANG Baojun, QU Yun, LI Bingjie, MEI Liping, the Writing Committee of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases. Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Excerpt)——Chapter Eight Cerebrovascular Disease Rehabilitation Management [J]. Chinese Journal of Stroke, 2023, 18(9): 1036-1048. |
[10] | WANG Lijia, SHI Dai, LIU Huihui, CAO Yongjun, LIU Chunfeng, SHI Jijun. Ischemic Stroke Caused by Internal Carotid Artery Dissection Associated with Styloid Process Syndrome: A Case Report [J]. Chinese Journal of Stroke, 2023, 18(9): 1049-1053. |
[11] | ZU Yu, YU Shasha, ZHANG Yujing, LYU Jing, FENG Xuedan. Heterozygous HTRA1-related Hereditary Cerebral Small Vessel Disease: A Case Report and Literature Review [J]. Chinese Journal of Stroke, 2023, 18(9): 1054-1059. |
[12] | REN Xiaojia, LIU Guanjie, HAO Wenqiang. A Case Report on the Treatment of Ischemic Stroke Caused by Moyamoya Disease with Ginaton [J]. Chinese Journal of Stroke, 2023, 18(9): 1060-1064. |
[13] | LU Jing, LI Chuanfa, ZHANG Daqi, CHEN Rong, LI Qifu. Research Progress of Hemorrhagic Transformation after Endovascular Treatment in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2023, 18(9): 1065-1072. |
[14] | ZHOU Yumeng, CHEN Lixia. Progress on Blood Pressure Management in Patients with Acute Ischemic Stroke Undergoing Mechanical Thrombectomy [J]. Chinese Journal of Stroke, 2023, 18(9): 1073-1078. |
[15] | LI Chao, JIANG Yingyu, ZHANG Xinmiao, YANG Xin, WANG Chunjuan, GU Hongqiu, DU Kejin, WANG Yongjun, LI Zixiao. Risk Factors of Hemorrhagic Transformation after Ischemic Stroke [J]. Chinese Journal of Stroke, 2023, 18(9): 1079-1084. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||